Breaking
Friday, June 19, 2026

Drug Approvals

🇺🇸 FDA Page 9

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.

Showing 97–108 of 665 articles

High impact NewsJun 4, 2026

Pharma in Focus: Regulatory Updates You Need to Know

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

FDA Flashback: Key Breast Cancer Decisions from April 2026

FDA · breast cancer · 7 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

FDA Approves First Oral COVID-19 PEP Drug, Xocova

FDA · COVID-19 · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 4, 2026

Pfizer sharpens prostate cancer case with Talzenna win — oncology

oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Explaining Unapproved Drugs to Payors: FDA Guidance Helps Pharma Avoid Pitfalls

FDA · 7 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

The Military's Role in the Rising Tide of Eating Disorders

eating disorders · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

AstraZeneca's Camizestrant: Navigating Divergent Regulatory Paths for Breast Cancer Treatment

FDA · breast cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

FDA Blueprint Aims to Reduce Regulatory Risks for Animal Testing Alternatives

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Why Optimistic Scientists Are Losing Heart: Insights from MIT

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

China’s Rise in Drug Development Looms Over U.S. Oncology Market

FDA · oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer

FDA · breast cancer · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Impact of CDER Leadership Changes on Pharma Strategy

FDA · 5 min

Dr. Sarah Mitchell